Jason Haas
Director of Finance/CFO presso SYROS PHARMACEUTICALS, INC.
Patrimonio netto: 434 353 $ in data 31/03/2024
Profilo
Jason Haas is an Independent Director at Ligand Pharmaceuticals, Inc. and the Chief Financial Officer at Syros Pharmaceuticals, Inc. He completed his undergraduate degree at Colgate University and his MBA at Columbia Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 09/06/2023 | 4 145 ( 0.02% ) | 303 000 $ | 31/03/2024 | |
| 01/04/2024 | 24 552 ( 0.09% ) | 131 353 $ | 31/03/2024 |
Posizioni attive di Jason Haas
| Società | Posizione | Inizio |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Director of Finance/CFO | 12/10/2021 |
| LIGAND PHARMACEUTICALS INCORPORATED | Director/Board Member | 29/06/2022 |
Formazione di Jason Haas
| Colgate University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| SYROS PHARMACEUTICALS, INC. | Health Technology |
- Borsa valori
- Insiders
- Jason Haas
